Close

Horizon Therapeutics' (HZNP) Tepezza Sales Rebound in April, Commentary from the Jefferies Healthcare Conference

Go back to Horizon Therapeutics' (HZNP) Tepezza Sales Rebound in April, Commentary from the Jefferies Healthcare Conference
HORIZON PHARMA (NASDAQ: HZNP) Delayed: 116.30 --0 (-0%)
Previous Close $116.30    52 Week High $23.44 
Open $116.30    52 Week Low $13.06 
Day High $116.30    P/E N/A 
Day Low $116.30    EPS $-0.96 
Volume 2,566